Patrick Demkowicz
About Patrick Demkowicz
Patrick Demkowicz is an Analyst in Clinical Development currently working at Roivant Sciences and serving as a Canaan-Yale Fellow at Canaan Partners. He has experience in health policy and biomarker discovery, with a background in medicine from Yale University.
Work at Roivant Sciences
Patrick Demkowicz has been employed at Roivant Sciences as an Analyst in Clinical Development since 2018. In this role, he contributes to the analysis and development of clinical strategies and projects. His experience in this position spans six years, during which he has engaged in various initiatives aimed at advancing clinical research and development within the organization.
Current Role at Canaan Partners
Since 2020, Patrick has served as a Canaan-Yale Fellow at Canaan Partners in Menlo Park, California. This fellowship, which is part of a collaboration between Canaan Partners and Yale University, allows him to apply his analytical skills in a venture capital setting, focusing on healthcare investments and innovation.
Previous Experience in Health Policy
Patrick worked as a Health Policy Intern at the Senate Committee on Health, Education, Labor, and Pensions in 2017. His internship lasted three months and took place in Washington, D.C. During this time, he gained insights into health policy formulation and legislative processes.
Education and Expertise
Patrick Demkowicz earned a Bachelor of Science degree from Yale University, completing his studies from 2014 to 2018. He is currently pursuing a Doctor of Medicine degree at Yale University School of Medicine, with an expected completion date in 2024. His educational background provides him with a strong foundation in both clinical and research methodologies.
Internship Experience at Genentech and The Jackson Laboratory
In 2016, Patrick interned at Genentech, focusing on immunology and tissue growth and repair biomarker discovery for two months. Additionally, he participated in a summer student program at The Jackson Laboratory from 2015 to 2016, where he worked as a fellow for seven months. These experiences contributed to his understanding of biomedical research and development.